Invention Grant
- Patent Title: Diacylglycerol acyl transferase 2 inhibitor
-
Application No.: US17062982Application Date: 2020-10-05
-
Publication No.: US11471458B2Publication Date: 2022-10-18
- Inventor: David James Edmonds , Kevin James Filipski , Kentaro Futatsugi , Michelle Renee Garnsey , Jack Chang Hung Lee , Daniel Jonathan Smaltz
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Lisa A. Samuels
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61P3/06 ; A61K31/155 ; A61K31/4545 ; C07D401/14 ; A61K31/4985 ; A61K31/7048 ; A61K45/06

Abstract:
Described herein are compounds of Formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 are defined herein, their use as diacylglycerol acyltransferase 2 (DGAT2) inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, NASH.
Public/Granted literature
- US20210100796A1 DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITOR Public/Granted day:2021-04-08
Information query
IPC分类: